|
For the past 20 years, Ms. Adler has counseled pharmaceutical and biotechnology companies on the full range of intellectual property, business development, research and development, and litigation issues, with particular focus on the strategic aspects of intellectual property law. Her expertise encompasses licensing and corporate partnering, research and development, manufacturing, clinical trials, product marketing, and disclosure and compliance. Prior to joining Raven, Ms. Adler led the intellectual property and general legal practice at COR Therapeutics Inc. for eight years, most recently as Vice President, Intellectual Property. Previous positions include five years as a patent attorney at Genentech, Inc. and several years as a legal consultant to biotechnology and pharmaceutical companies and in private practice. Ms. Adler received a BA from Brown University and was a research fellow at the National Cancer Institute. She received a JD from the SCALE Program at Southwestern University School of Law. | 